Home › Funds › SILVERCREST ASSET MANAGEMENT GROUP LLC › CVS

SILVERCREST ASSET MANAGEMENT GROUP LLC position in CVS

CVS HEALTH CORP · Consumer Staples

SILVERCREST ASSET MANAGEMENT GROUP LLC reported holding 717,903 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$74.3M, representing 0.49% of its reported portfolio and ranking #49 among its reported holdings. SILVERCREST ASSET MANAGEMENT GROUP LLC has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)717.90K sh
Reported value held$74.27M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SILVERCREST ASSET MANAGEMENT GROUP LLC's CVS position evolved

SILVERCREST ASSET MANAGEMENT GROUP LLC first disclosed a stake in CVS in Q3 2023 at 1,329,219 shares (US$92.8M). The position peaked in Q1 2024 at 1,362,974 shares, worth US$108.7M. Across 12 filings, SILVERCREST ASSET MANAGEMENT GROUP LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 717,903 shares valued at US$74.3M — a reduction of -61,845 shares quarter over quarter.. Notable position changes include a 25% trim in Q4 2024 (shares rose 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.33M $92.81M New
Q4 2023 1.36M $107.37M Add
Q1 2024 1.36M $108.71M Hold
Q2 2024 1.28M $75.56M Reduce
Q3 2024 1.22M $76.69M Reduce
Q4 2024 913.99K $41.03M Reduce
Q1 2025 1.01M $68.31M Add
Q2 2025 974.09K $67.19M Reduce
Q3 2025 922.03K $69.51M Reduce
Q4 2025 880.19K $69.85M Reduce
Q1 2026 779.75K $56.00M Reduce
Q2 2026 717.90K $74.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has SILVERCREST ASSET MANAGEMENT GROUP LLC held CVS?

SILVERCREST ASSET MANAGEMENT GROUP LLC has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SILVERCREST ASSET MANAGEMENT GROUP LLC's current position in CVS?

As of Q2 2026, SILVERCREST ASSET MANAGEMENT GROUP LLC holds 717.90K shares of CVS (CVS HEALTH CORP), valued at $74.27M, representing 0.49% of its reported portfolio and ranking #49.

Has SILVERCREST ASSET MANAGEMENT GROUP LLC been buying or selling CVS?

In the latest 13F filing (Q2 2026), SILVERCREST ASSET MANAGEMENT GROUP LLC reduced its position in CVS. The position peaked in Q1 2024 at 1.36M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.